LaunchCyte
VC Fund
Pittsburgh, United States
LaunchCyte is a VC fund in Pittsburgh focused on Medical and Health Care. LaunchCyte creates life sciences companies. Since their founding in 2000, they have created six companies that offer unique technologies and products to improve healthcare and the human condition. They search for the most exciting technologies from leading research universities and form companies to commercialize the innovations.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries LaunchCyte invests in
Stages LaunchCyte invests in
Countries LaunchCyte invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Babs Carryer
|
|||
Tom Petzinger
|
|||
Investment Focus
Industry
- Medical 1 (33%)
- Health Care 1 (33%)
- Biotechnology 1 (33%)
- Health Diagnostics 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Series C 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Babs Carryer
Co-founder
|
Co-founder | Total investments: 0 | Find email | |
|
Tom Petzinger
Co-Founder
|
Co-Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Knopp Biosciences
|
Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetictesting. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania. | $30M / Series C / Dec 03, 2012 | |
|
Knopp Biosciences
|
Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetictesting. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania. | $10M / Series B / Jan 22, 2008 | |
|
Knopp Biosciences
|
Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetictesting. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families.Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania. | $10M / Series A / Jan 01, 2006 |
Co-Investors
Kramer Capital Partners
3 deals together
Saturn Partners
3 deals together
Biogen
1 deal together
Innovation Works
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does LaunchCyte invest in?
LaunchCyte invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact LaunchCyte?
Public channels for LaunchCyte include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at LaunchCyte?
The team at LaunchCyte includes Babs Carryer (Co-founder) and Tom Petzinger (Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
